|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|
| Assets [abstract] | |||||||
| Noncurrent assets | |||||||
| Property, plant and equipment | |||||||
| Goodwill | |||||||
| Other intangible assets | |||||||
| Right-of-use assets | |||||||
| Biological assets | |||||||
| Investments in associates | |||||||
| Trade and other receivables | |||||||
| Deferred income tax assets | |||||||
| Total noncurrent assets | |||||||
| Current assets | |||||||
| Inventories | |||||||
| Trade and other receivables | |||||||
| Cash, bank balances and other short-term investments | |||||||
| Total current assets | |||||||
| Total assets | |||||||
| Equity and liabilities | |||||||
| Equity | |||||||
| Capital stock | |||||||
| Other equity instruments | |||||||
| Legal reserve | |||||||
| Share-based payments | |||||||
| Share repurchase reserve | |||||||
| Other accumulated comprehensive income (losses) | |||||||
| Accumulated profit (losses) | |||||||
| Total equity | |||||||
| Liabilities | |||||||
| Noncurrent liabilities | |||||||
| Deferred income tax liabilities | |||||||
| Lease liabilities | |||||||
| Provisions | |||||||
| Borrowings | |||||||
| Employee benefits | |||||||
| Income tax liability | |||||||
| Trade and other payables | |||||||
| Total noncurrent liabilities | |||||||
| Current liabilities | |||||||
| Provisions | |||||||
| Lease liabilities | |||||||
| Borrowings | |||||||
| Salaries and payroll taxes | |||||||
| Income tax liability | |||||||
| Other taxes and royalties | |||||||
| Trade and other payables | |||||||
| Total current liabilities | |||||||
| Total liabilities | |||||||
| Total equity and liabilities | |||||||
Loading...